Soros Fund Management LLC Cuts Holdings in Beyond Air, Inc. (NASDAQ:XAIR)

Soros Fund Management LLC lowered its stake in shares of Beyond Air, Inc. (NASDAQ:XAIR) by 32.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,000,000 shares of the company’s stock after selling 476,626 shares during the quarter. Soros Fund Management LLC’s holdings in Beyond Air were worth $358,000 at the end of the most recent quarter.

Separately, Baldwin Wealth Partners LLC MA increased its stake in Beyond Air by 721.3% in the fourth quarter. Baldwin Wealth Partners LLC MA now owns 308,000 shares of the company’s stock valued at $110,000 after acquiring an additional 270,500 shares during the last quarter. Hedge funds and other institutional investors own 31.50% of the company’s stock.

Insider Transactions at Beyond Air

In other Beyond Air news, Director Robert Carey bought 1,000,000 shares of the firm’s stock in a transaction that occurred on Friday, March 14th. The shares were bought at an average price of $0.25 per share, for a total transaction of $250,000.00. Following the transaction, the director now directly owns 4,076,864 shares in the company, valued at $1,019,216. This trade represents a 32.50 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 20.10% of the company’s stock.

Beyond Air Stock Down 0.7 %

NASDAQ XAIR opened at $0.20 on Wednesday. The stock’s 50-day simple moving average is $0.26 and its two-hundred day simple moving average is $0.37. Beyond Air, Inc. has a twelve month low of $0.19 and a twelve month high of $1.49. The company has a market capitalization of $13.87 million, a price-to-earnings ratio of -0.19 and a beta of 0.15.

Beyond Air (NASDAQ:XAIR) last announced its quarterly earnings data on Monday, February 10th. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.09. Beyond Air had a negative return on equity of 226.01% and a negative net margin of 1,730.00%. During the same quarter in the previous year, the business posted ($0.50) EPS. On average, equities analysts expect that Beyond Air, Inc. will post -0.79 earnings per share for the current fiscal year.

Beyond Air Profile

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.